May 22, 2017
2 min read
Save

Psoriasis, sunscreen studies top dermatology reads for week

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study results finding that most people incorrectly applied free sunscreen when it was provided at a state fair was among the top read articles of the past week on Healio.com/Dermatology.

Other widely-read articles included study results finding that patients with psoriasis treated with biologics have minimal risk of hepatitis B and C reactivation:

Most people incorrectly applied free sunscreen at public event

When free sunscreen was made available at the Minnesota State Fair, only one-third of the participants applied sunscreen to all sun-exposed areas, according to recent research published in the Journal of the American Academy of Dermatology.

Complimentary sunscreen dispensers were installed at 10 information booths at the 12-day Minnesota State Fair, which attracts more than 1.7 million attendees each August. Read more

Patients with psoriasis treated with biologics have minimal risk of hepatitis B, C reactivation

Patients with moderate-to-severe psoriasis without hepatitis who were seropositive for hepatitis B core antibody only or hepatitis C infection, and who were being treated with biologic therapies, had minimal or no risk for viral reactivation, according to study results recently published in the Journal of the American Academy of Dermatology.

“Up to 37.2% of patients with moderate-to-severe psoriasis are treated with biologic therapies,” Igor Snast, MD, of the dermatology department, Rabin Medical Center Beilinson Hospital, Petach Tikva, Israel, and colleagues wrote. “Therefore, it is crucial to define the safety profile of these agents in patients with concurrent serology suggestive of viral hepatitis.” Read more

Reflectance confocal microscopy distinguishes lip melanoma from benign melanotic macules

In vivo reflectance confocal microscopy can be used to distinguish between benign melanotic macules and lip melanoma, according to study results recently published in JAMA Dermatology.

Researchers conducted a retrospective observational study of 31 patients from two referral centers for melanoma in Australia, who were recruited between June 2007 and January 2015, and separated into two groups. Read more

Patients perceived as younger, more successful after undergoing facial rejuvenation surgery

Patients who underwent face-lift and upper facial rejuvenation surgery were perceived as younger, more attractive and more successful by observers, according to survey results recently published in JAMA Facial Plastic Surgery.

Researchers conducted web-based surveys featuring photographs of patients before and after facial rejuvenation surgery. Read more

Topical ruxolitinib provides repigmentation in patients with facial vitiligo

Patients with facial vitiligo experienced significant repigmentation after treatment with topical ruxolitinib 1.5% cream, according to study results.

The researchers conducted a 20-week, open-label, proof-of-concept study at Tufts Medical Center in Boston of 11 patients (54.5% men; mean age, 52 years) with a minimum of 1% affected body surface are of vitiligo. Read more